Compare Houlihan Lokey, Inc. (HLI) vs Morgan Stanley (MS) Stock

Morgan Stanley (MS) offers the better valuation at 20.9x trailing P/E (14.8x forward), making it the more compelling value choice. Analysts rate Houlihan Lokey, Inc. (HLI) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Morgan Stanley (MS) is the cheapest at 20.9x versus Houlihan Lokey, Inc. at 28.1x. On forward P/E, Morgan Stanley is actually cheaper at 14.8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Houlihan Lokey, Inc. wins at 1.32x versus Morgan Stanley's 1.66x — a reasonable growth-adjusted valuation.

Over the past 5 years, Houlihan Lokey, Inc. (HLI) delivered a total return of +167.7%, compared to +131.0% for Morgan Stanley (MS). A $10,000 investment in HLI five years ago would be worth approximately $27K today (assuming dividends reinvested). Over 10 years, the gap is even starker: MS returned +662.8% versus HLI's +601.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Houlihan Lokey, Inc. (HLI) is the lower-risk stock at 0.98β versus Morgan Stanley's 1.35β — meaning MS is approximately 39% more volatile than HLI relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.

Houlihan Lokey, Inc. (HLI) is the more profitable company, earning 16.7% net margin versus 13.0% for Morgan Stanley — meaning it keeps 16.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLI leads at 21.0% versus 17.1% for MS. At the gross margin level — before operating expenses — MS leads at 55.6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential. By this metric, Houlihan Lokey, Inc. (HLI) is the more undervalued stock at a PEG of 1.32x versus Morgan Stanley's 1.66x. A PEG below 1.5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Morgan Stanley (MS) trades at 14.8x forward P/E versus 20.8x for Houlihan Lokey, Inc. — 6.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLI: 25.6% to $205.67.

All stocks in this comparison pay dividends. Morgan Stanley (MS) offers the highest yield at 2.3%, versus 1.5% for Houlihan Lokey, Inc. (HLI).

For long-horizon retirement investors, Houlihan Lokey, Inc. (HLI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.98), 1.5% yield, +601.0% 10Y return). Both have compounded well over 10 years (HLI: +601.0%, MS: +662.8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.